A Authors’ contributions and Research funding | 205 Timon A. Bloedjes (T.A.B): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Chiel Maas (C.M): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Alexander M. de Bruin (A.M.d.B): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Richard J. Bende (R.J.B): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Amelie van der Veen (A.vdV.): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Harmen van Andel (H.vA.): Department of Pathology, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, the Netherlands Lymphoma and Myeloma Center Amsterdam (LYMMCARE), the Netherlands Carol E. Schrader (C.E.S.): Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01655 Rudi W. Hendriks (R.W.H.): Department of Pulmonary Medicine, Erasmus MC, 3000 CA Rotterdam, the Netherlands
RkJQdWJsaXNoZXIy MTk4NDMw